Your browser doesn't support javascript.
loading
Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling.
Rajoli, Rajith K R; Curley, Paul; Chiong, Justin; Back, David; Flexner, Charles; Owen, Andrew; Siccardi, Marco.
Afiliação
  • Rajoli RKR; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Curley P; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Chiong J; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Back D; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Flexner C; Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, Maryland.
  • Owen A; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
  • Siccardi M; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
J Infect Dis ; 219(11): 1735-1742, 2019 05 05.
Article em En | MEDLINE | ID: mdl-30566691

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridonas / Rifampina / Infecções por HIV / Antirretrovirais / Rilpivirina Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridonas / Rifampina / Infecções por HIV / Antirretrovirais / Rilpivirina Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido